Journal of Medicinal Chemistry · 2008 · 21 citations · 19 references
PharmacyMedicinal ChemistryPharmacologyBioavailabilityDrug DesignDrug DiscoveryLead Compound DesignLead DiscoveryPharmacokinetic OptimizationPotency OptimizationStereochemical OptimizationStructure-activity Relationship AnalysisBenzoic Acid DerivativesChemical Synthesis Of AnaloguesCompound Potency OptimizationMedicinal Chemistry ApplicationsOptimization Of Pharmacokinetic PropertiesSelectivityStereoselective SynthesisStructure-based Lead Discovery
We designed a series of benzoic acid derivatives containing the biphenyl ether or biphenyl template on the RHS and a phenylethanolaminotetraline (PEAT) skeleton, which was prepared by highly stereoselective synthesis, to generate two structurally different lead compounds ( 10c, 10m) with a good balance of potency, selectivity, and pharmacokinetic profile. Further optimization of the two lead compounds to improve potency led to several potential candidates (i.e., 11f, 11l, 11o, 12b). In particular, biphenyl analogue 12b exhibited an excellent balance of high potency (EC50 = 0.38 nM) for beta3, high selectivity over beta1 and beta2, and good pharmacokinetic properties in rats, dogs, and monkeys.
19
Molecular Characterization of the Human β <sub>3</sub> -Adrenergic Receptor
Laurent J. Emorine, Stéfano Marullo, Marie‐M. BRIEND‐SUTREN et al. · Science · 1989 · 1.1K citations
Atypical β-adrenoceptor on brown adipocytes as target for anti-obesity drugs
Jonathan R.S. Arch, A. T. Ainsworth, Michael A. Cawthorne et al. · Nature · 1984 · 730 citations